Ibutilide

This classification denotes a cation channel blocker and antiarrhythmic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 2436VX1U9B. European Medicines Agency schedules Ibutilide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08102MIG. Ibutilide generally arises in the molecular formula C20H36N2O3S. The term IBUTILIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 5, No. 3 1991, list 31.) IBUTILIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule ibutilide under HS 29350090 and SITC 51580. As of Q4 2014, IBUTILIDE remains US FDA's Preferred Term for this commodity. Ibutilide bears US NLM identifiers UMLS ID C0082966 and NCI Concept Code C72581. SMILES: S(=O)(=O)(NC1CCC(C(O)CCCN(CCCCCCC)CC)CC1)C.